Exploring Carbidopa-Levodopa for Treating Parkinson's Symptoms episode artwork

EPISODE · Mar 5, 2024 · 31 MIN

Exploring Carbidopa-Levodopa for Treating Parkinson's Symptoms

from Substantial Matters: Life & Science of Parkinson's

Carbidopa-levodopa is considered the "gold standard treatment" for Parkinson's disease. Levodopa works to replace levels of dopamine in the brain, thereby alleviating PD symptoms, while Carbidopa works to reduce adverse effects in the rest of the body. Although years have passed since the creation of this treatment, it is still commonly known to be an effective drug for reducing PD symptoms in a majority of people living with Parkinson's. In this episode, we hear from Dr. Emily Peron, PharmD and Dr. Leslie Cloud, MD from Virginia Commonwealth University*. They discuss how and why carbidopa-levodopa continues to be a standard treatment for PD, long-term use considerations, its different forms, and when to recognize the need for potential medication adjustments. *Denotes a Parkinson's Foundation Center of Excellence

Episode metadata supplied by the publisher feed · Published Mar 5, 2024

Embed this episode

Ready to play

Exploring Carbidopa-Levodopa for Treating Parkinson's Symptoms

0:00 31:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Substantial Matters: Life & Science of Parkinson's?

This episode is 31 minutes long.

When was this Substantial Matters: Life & Science of Parkinson's episode published?

This episode was published on March 5, 2024.

Can I download this Substantial Matters: Life & Science of Parkinson's episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!